This Intrepid Explorer of the Markets Is Back

Stansberry Investor Hour

Stansberry Research

America, How, To, Crash, Money, Learn, Stansberry, Income, Research, Debt, Stocks, Porter, Business, Realestate, Banking, Investment, American, Investing, Invest, Howtosave, Sjuggerud, Ferris, Eifrig, Jubilee, Buck, Sexton, Market, Bonds, Churchouse, Savings, Options, Lashmet

4.4 • 677 Ratings

🗓️ 17 October 2022

⏱️ 70 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week, we've brought back Stansberry Venture Technology editor Dave Lashmet.

Dave mines the markets for lucrative opportunities in publicly traded, small-cap companies. A typical "diamond in the rough" might pioneer a revolutionary new drug or technology. These early-stage innovators can potentially change the world for the better – and rake in outsized gains for investors. And the best part about investing in these kinds of companies lies in their resilience to bear markets like today's...

Dave rejoins us today with a special look into some of the most promising new trends in the biotech space. You'll hear about a leader in robotic surgery... cutting-edge radiation therapy that Dave has been tracking for several years... new breakthroughs in cancer treatment... and the true story – one that leaves Dan momentarily speechless – of a man who overcame life-changing, traumatic injuries to become a crusader for patient rights.

Transcript

Click on a timestamp to play from that location

0:00.0	Hello and welcome to the Stansberry Investor Hour.
0:09.0	I'm your host, Dan Ferris.
0:10.5	I'm also the editor of Extreme Value published by Stansberry Research.
0:14.8	And I'm Corey McLaughlin.
0:15.8	I'm the editor of the Stansbury Digest.
0:18.1	This week, Dan talks to our friend Dave Lashman, editor of Stansberry Venture
0:21.8	Technology. And for our opening rant, mixed signals from the Fed and Janet Yallen, CPI report,
0:29.1	and more. No mailbag this week, but remember, you can email us at Feedback at InvestorHour.com
0:34.4	or call our listener feedback line 800381-57, and tell us what's on your mind.
0:40.2	That and more right now on the Stansberry Investor Hour.
0:53.3	First thing that I can't avoid talking about this week, of course, is the CPI print,
1:01.9	which is still high.
1:04.0	I mean, it's elevated, right?
1:06.3	It's 8.2%.
1:08.3	So nothing's changing.
1:14.3	There's still plenty of inflation. I continue to believe that inflation is a much stickier phenomenon than anybody seems to fathom. But stocks go up, right?
1:20.9	Right. Right. Now, you know, I don't know how to explain that, right? Some people say, well, look, now that we have the certainty of knowing what the number is, and it's been high for so long, I mean, you know, it's got to be peaking, right? It's got to be peaking, right?
1:39.1	I mean, it looks like it a little bit, but, you know, it's still at 40-year highs, which is what I wrote in the digest.
1:45.7	I mean, that's the main point, I think, that people, whoever is not paying attention
1:49.6	to that should remember that.
1:51.4	Yeah, I mean, I don't know.
1:52.5	I think, I think, I don't think it looks as peaky as that.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Stansberry Research, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Stansberry Research and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.